Is Bruker Corporation overvalued?

Bruker Corporation (BRKR) looks undervalued — trading about 17% below its fair value.

Undervalued

Price

$57.93

Fair value

$67.67

Current P/E

31.8

Normal P/E

37.2

Market cap

$8.82B

Dividend yield

0.4%

Return on equity

-2.9%

Sector

Healthcare

Fair value compares BRKR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks